Provasic

Provasic is a drug produced by Devlin MacGregor Pharmaceuticals which was announced as a non-invasive treatment for arterial plaque, one that would reduce the risks of heart attack and other heart problems. IN early tests, it was referred to as RDU-90.

Sadly, it was not as advertised. It caused severe liver damage in a small but significant number of patients it was administered to. The company was aware of this, and conspired to frame a Dr Richard Kimble for falsifying the tissue samples enabling FDA approval.

This scheme ultimately backfired, and Kimble exposed the conspirators with a little assistance from US Marshal Sam Gerard and his team. As a result, Provasic never went to market and several employees of Devlin MacGregor faced criminal charges for their roles in the conspiracy.